Sportsman Sportsman, SyntheMed vice president of sales, said: ‘We are delighted that these regulatory and clinical evaluation has been successfully completed, and we can go with the launch of REPEL – CV in this important market. ‘.. Open heart receives Russian regulatory approval for REPEL – CV SyntheMed, , a biomaterials company in the development and commercialization of anti-adhesion products, announced that REPEL – CV, the company bioresorbable Adhesion Barrier for the reduction of adhesions following cardiac surgery, has received the approval from the Ministry of health of the Russian Federation for use in all patients who undergo open-heart surgery. REPEL – CV will be marketed in Russia through cardio Medics, a distributor of cardiac surgery devices.
) has CE approval for use in all cardiac surgery patients and is Union and certain Union and certain other international countries through a network of independent distributors.
About adhesionsadhesions or scar tissue after virtually all open-heart surgical procedures occur, often resulting in the heart always to the sternum and other surrounding tissue surfaces. The presence of adhesions is a common and serious complication in secondary surgical procedures, increasing the length, cost and risk of the surgical procedure.. REPEL – CV is approved by the FDA for use in pediatric cardiac surgery patients and in the United States in the U.S.Total of 899 HIV / AIDS cases were report in the CR this year, compared 500 2000 reported. By the eight hundred and ninety-nine HIV / AIDS cases occured seven hundred sixty-four from sexual transmission, by Xinhua / People ‘s Daily occurred. Publish. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All Rights Reserved part.. HIV positive people Studio higher number of HIV / of the.
The Czech Republic is the inclusion a rising number of HIV / cases of AIDS, primarily because of the low levels of consciousness about the illness in young people and migrant flows into the country, according to a report on Wednesday carried by the National Reference Laboratory on AIDS, the country nation Institute of Public Health, Xinhua / People ‘s Daily.